Pengliang Xin

Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines

Pengliang Xin, Chuntuan Li, Yan Zheng et al. · Drug Design Development and Therapy · 2017 · 31 citations · Full text

The dual PI3K/mTOR inhibitor NVP-BEZ235 inhibits proliferation and induces apoptosis of burkitt lymphoma cells

Chuntuan Li, Pengliang Xin, Huifang Xiao et al. · Cancer Cell International · 2015 · 25 citations · Full text

<p>Protective autophagy or autophagic death: effects of BEZ235 on chronic myelogenous leukemia</p>

Pengliang Xin, Wenqian Xu, Xiongpeng Zhu et al. · Cancer Management and Research · 2019 · 10 citations · Full text

Calreticulin increases growth and progression of natural killer/T-cell lymphoma

Yan Zheng, Chuntuan Li, Pengliang Xin et al. · Aging · 2020 · 10 citations · Full text